Tokyo Tape
Sign in
← Hokuyaku Takeyama Holdings

Quarterly report · Q1

3055.TEDINET S100OVJX
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥63.9bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥248.4bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥60.4bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥402m2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥159m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥811m2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥3.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥508m2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥1.2bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥863m2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥831m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥645m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥831m2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥645m2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥139.3bnat 2022-06-30Cons.Assets
Total assets¥136.9bnat 2022-03-31Cons.Assets
Total assets¥136.7bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥83.5bnat 2022-06-30Cons.Liabilities
Total liabilities¥81.3bnat 2022-03-31Cons.Liabilities
Net assets / equity¥55.9bnat 2022-06-30Cons.Net assets
Net assets / equity¥55.5bnat 2022-03-31Cons.Net assets
Net assets / equity¥54.5bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥24.0bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥21.1bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥24.0bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥21.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥22.7bnat 2021-06-30Cons.Cash and cash equivalents
Cash & equivalents¥20.4bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥3.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.1bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities
Investing cash flow¥61m2022-04-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥332m2021-04-01 → 2021-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥191m2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥849m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥159m2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥36.862022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥123.442021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.842021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio40.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio40.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.8%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 56
SegmentItemPeriodValue
Otherother segmentsrevenue2022-04-01 → 2022-06-30¥1.3bn
Otherother segmentsrevenue external2022-04-01 → 2022-06-30¥17m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥1.3bn
Otherother segmentssegment profit2022-04-01 → 2022-06-30¥985m
jpcrp040300-q1r_E03003-000Dispensing Industryreportable segmentrevenue2022-04-01 → 2022-06-30¥3.3bn
jpcrp040300-q1r_E03003-000Dispensing Industryreportable segmentrevenue external2022-04-01 → 2022-06-30¥3.3bn
jpcrp040300-q1r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥2m
jpcrp040300-q1r_E03003-000Dispensing Industryreportable segmentsegment profit2022-04-01 → 2022-06-30−¥50m
jpcrp040300-q1r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2022-04-01 → 2022-06-30¥367m
jpcrp040300-q1r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2022-04-01 → 2022-06-30¥96m
jpcrp040300-q1r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥270m
jpcrp040300-q1r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2022-04-01 → 2022-06-30¥8m
jpcrp040300-q1r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2022-04-01 → 2022-06-30¥15.7bn
jpcrp040300-q1r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2022-04-01 → 2022-06-30¥15.6bn
jpcrp040300-q1r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥117m
jpcrp040300-q1r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2022-04-01 → 2022-06-30¥312m
jpcrp040300-q1r_E03003-000Nursing Industryreportable segmentrevenue2022-04-01 → 2022-06-30¥972m
jpcrp040300-q1r_E03003-000Nursing Industryreportable segmentrevenue external2022-04-01 → 2022-06-30¥972m
jpcrp040300-q1r_E03003-000Nursing Industryreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥0
jpcrp040300-q1r_E03003-000Nursing Industryreportable segmentsegment profit2022-04-01 → 2022-06-30¥68m
jpcrp040300-q1r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2022-04-01 → 2022-06-30¥46.2bn
jpcrp040300-q1r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2022-04-01 → 2022-06-30¥43.8bn
jpcrp040300-q1r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥2.4bn
jpcrp040300-q1r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2022-04-01 → 2022-06-30¥178m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥67.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥63.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥4.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.5bn
Otherother segmentsrevenue2021-04-01 → 2021-06-30¥770m
Otherother segmentsrevenue external2021-04-01 → 2021-06-30¥16m
Otherother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥754m
Otherother segmentssegment profit2021-04-01 → 2021-06-30¥422m
jpcrp040300-q1r_E03003-000Dispensing Industryreportable segmentrevenue2021-04-01 → 2021-06-30¥3.3bn
jpcrp040300-q1r_E03003-000Dispensing Industryreportable segmentrevenue external2021-04-01 → 2021-06-30¥3.3bn
jpcrp040300-q1r_E03003-000Dispensing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥3m
jpcrp040300-q1r_E03003-000Dispensing Industryreportable segmentsegment profit2021-04-01 → 2021-06-30−¥14m
jpcrp040300-q1r_E03003-000Information And Communication Technology Industryreportable segmentrevenue2021-04-01 → 2021-06-30¥324m
jpcrp040300-q1r_E03003-000Information And Communication Technology Industryreportable segmentrevenue external2021-04-01 → 2021-06-30¥94m
jpcrp040300-q1r_E03003-000Information And Communication Technology Industryreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥229m
jpcrp040300-q1r_E03003-000Information And Communication Technology Industryreportable segmentsegment profit2021-04-01 → 2021-06-30¥18m
jpcrp040300-q1r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue2021-04-01 → 2021-06-30¥14.9bn
jpcrp040300-q1r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue external2021-04-01 → 2021-06-30¥14.7bn
jpcrp040300-q1r_E03003-000Medical Equipment Wholesale Industryreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥132m
jpcrp040300-q1r_E03003-000Medical Equipment Wholesale Industryreportable segmentsegment profit2021-04-01 → 2021-06-30¥240m
jpcrp040300-q1r_E03003-000Nursing Industryreportable segmentrevenue2021-04-01 → 2021-06-30¥936m
jpcrp040300-q1r_E03003-000Nursing Industryreportable segmentrevenue external2021-04-01 → 2021-06-30¥932m
jpcrp040300-q1r_E03003-000Nursing Industryreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥4m
jpcrp040300-q1r_E03003-000Nursing Industryreportable segmentsegment profit2021-04-01 → 2021-06-30¥50m
jpcrp040300-q1r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue2021-04-01 → 2021-06-30¥43.6bn
jpcrp040300-q1r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue external2021-04-01 → 2021-06-30¥41.3bn
jpcrp040300-q1r_E03003-000Wholesaler Of Drugs Industryreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥2.3bn
jpcrp040300-q1r_E03003-000Wholesaler Of Drugs Industryreportable segmentsegment profit2021-04-01 → 2021-06-30−¥37m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥63.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥60.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥3.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥679m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 499
ItemContextValueUnit
LiabilitiesPrior1YearInstant81340000000JPY
LiabilitiesCurrentQuarterInstant83453000000JPY
Capital stockPrior1YearInstant1000000000JPY
Capital stockCurrentQuarterInstant1000000000JPY
Capital surplusPrior1YearInstant11821000000JPY
Capital surplusCurrentQuarterInstant11821000000JPY
Retained earningsPrior1YearInstant38965000000JPY
Retained earningsCurrentQuarterInstant39582000000JPY
Treasury stockPrior1YearInstant-1325000000JPY
Treasury stockCurrentQuarterInstant-1709000000JPY
Shareholders equityPrior1YearInstant50461000000JPY
Shareholders equityCurrentQuarterInstant50695000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant5909000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant5978000000JPY
Revaluation reserve for landPrior1YearInstant-742000000JPY
Revaluation reserve for landCurrentQuarterInstant-742000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-96000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-91000000JPY
Valuation and translation adjustmentsPrior1YearInstant5070000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant5145000000JPY
Non controlling interestsPrior1YearInstant11000000JPY
Non controlling interestsCurrentQuarterInstant11000000JPY
Net assetsPrior1YearInstant55543000000JPY
Net assetsCurrentQuarterInstant55851000000JPY
Liabilities and net assetsPrior1YearInstant136883000000JPY
Liabilities and net assetsCurrentQuarterInstant139305000000JPY
Net salesPrior1YTDDuration60426000000JPY
Net salesCurrentYTDDuration63855000000JPY
Cost of salesPrior1YTDDuration56070000000JPY
Cost of salesCurrentYTDDuration59106000000JPY
Gross profitPrior1YTDDuration4355000000JPY
Gross profitCurrentYTDDuration4749000000JPY
Packing expenses sgaPrior1YTDDuration276000000JPY
Packing expenses sgaCurrentYTDDuration267000000JPY
Salaries sgaPrior1YTDDuration1883000000JPY
Salaries sgaCurrentYTDDuration1948000000JPY
Provision for bonuses sgaPrior1YTDDuration423000000JPY
Provision for bonuses sgaCurrentYTDDuration435000000JPY
Provision for directors bonuses sgaPrior1YTDDuration27000000JPY
Provision for directors bonuses sgaCurrentYTDDuration28000000JPY
Retirement benefit expenses sgaPrior1YTDDuration87000000JPY
Retirement benefit expenses sgaCurrentYTDDuration88000000JPY
Legal and employee benefits expenses sgaPrior1YTDDuration385000000JPY
Legal and employee benefits expenses sgaCurrentYTDDuration389000000JPY
Rent expenses sgaPrior1YTDDuration72000000JPY
Rent expenses sgaCurrentYTDDuration71000000JPY
Other sgaPrior1YTDDuration1040000000JPY
Other sgaCurrentYTDDuration1117000000JPY
Selling general and administrative expensesPrior1YTDDuration4196000000JPY
Selling general and administrative expensesCurrentYTDDuration4346000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass